NCT07179055PHASE2Recruiting
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Vanda Pharmaceuticals
Start Date
10/1/2025
Completion Date
9/1/2026
Summary
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Be at least 18 years of age of either gender and any race.
* Provide written informed consent and sign the HIPAA form.
* Be willing and able to follow all instructions and attend all study visits.
Exclusion Criteria:
* Use of any of the disallowed medications during the washout and study period.
Interventions
DRUG
VSJ-110
DRUG
Placebo
Conditions
Dry Eye
Locations
Vanda Investigational Site
Newport Beach, California 92663
United States
Vanda Investigational Site
Andover, Massachusetts 01810
United States
Vanda Investigational Site
Shelby, North Carolina 28150
United States
Vanda Investigational Site
Memphis, Tennessee 38119
United States
Vanda Investigational Site
Lynchburg, Virginia 24502
United States